SNX Price Prediction Next Week
Technical Analysis: TD Synnex (SNX) shows strong bullish momentum with RSI-14 at 67.43, indicating an upward trend but not yet overbought. The stock is trading above all major moving averages (SMA 5, 10, 20, 60, 200), suggesting robust long-term strength.
Price Levels and Fibonacci Analysis:
- Current Price: $144.42
- Key Resistance: $145.39 (Fibonacci R2)
- Key Support: $141.80 (Fibonacci Pivot)
- Secondary Support: $139.58 (Fibonacci S1)
News Impact: Barclays recently raised the price target to $148 from $132 while maintaining an Equal Weight rating, citing better-than-expected Q4 results and fiscal 2025 guidance. However, they remain cautious due to near-term margin uncertainties in the Hyve business.
Next Week Price Prediction: Based on technical indicators and recent price action:
- Bullish Target: $147.61 (Fibonacci R3)
- Base Case Target: $145.39 (Fibonacci R2)
- Bearish Target: $141.80 (Fibonacci Pivot)
Trading Recommendation: BUY with entry at current levels ($144.42) with a stop loss at $141.80. The stock shows strong momentum and positive analyst sentiment, suggesting potential upside to $147.61 in the coming week. The stock's position above all major moving averages and strong RSI readings support this bullish outlook.
SNX Similar Chart Price Prediction
The price of SNX is predicted to go up 1.13%, based on the high correlation periods with FAST. The similarity of these two price pattern on the periods is 98.65%.
SNX
FAST
Up: 1.13%Similarity: 98.65%
SNX Revenue Forecast
SNX EPS Forecast
SNX FAQs
What is bull’s view on SNX?
What is bear's view on SNX?
What is SNX revenue forecast for next quarter？
What is SNX eps forecast for next quarter？
SNX Analyst's Forecast
Tim Long
Barclays
Hold
2025-01-13
Price Target
$132 → $148
Upside
+11.41%
Barclays raised the firm's price target on TD Synnex to $148 from $132 and keeps an Equal Weight rating on the shares. The company reported better than expected Q4 results with a fiscal 2025 guidance relatively in line with expectations, the analyst tells investors in a research note. The firm says that while the shares are inexpensive, it remains on the sidelines due to near-term margin uncertainty around the Hyve business and uneven end market recovery.
Ashish Sabadra
RBC Capital
Buy
2025-01-07
Price Target
$140
Upside
+13.61%
Ananda Baruah
Loop Capital
Strong Buy
2024-10-07
Price Target
$150
Upside
+26.11%
